MAPK3 and urinary bladder cancer: Furthermore, naringin activates the MAPK signal transduction pathways by elevating the phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2), p38 MAPK, and JNK in 5637 bladder cancer cells (51).